Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation (PLos Medicine (2007) 4, 7, DOI: 10.1371/journal.pmed.0040242);Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation

PLoS Medicine

Volumn 4, Issue 7, 2007, Pages 1259-1267

  Aponte, John J ^a,d   Menendez, Clara ^a,b   Schellenberg, David ^a,c   Kahigwa, Elizeus ^c   Mshinda, Hassan ^c   Vountasou, Penelope ^d   Tanner, Marcel ^d   Alonso, Pedro L ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MALOPRIM; PLACEBO; DAPSONE; PARASITE ANTIGEN; PYRIMETHAMINE;

AGE; ANEMIA; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEVER; FOLLOW UP; GROUPS BY AGE; HOSPITAL; HUMAN; INCIDENCE; INFANCY; INFANT; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MORBIDITY; OUTCOME ASSESSMENT; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TANZANIA; ANIMAL; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; TREATMENT OUTCOME;

AGE FACTORS; ANEMIA; ANIMALS; ANTIGENS, PROTOZOAN; CHILD, PRESCHOOL; DAPSONE; DRUG THERAPY, COMBINATION; HUMANS; INCIDENCE; INFANT; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; TANZANIA; TREATMENT OUTCOME;

EID: 34547584437     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040359     Document Type: Erratum

References (26)

1. Ross R (1910) The prevention of malaria. London: John Murray. 669 p.
2. Stevenson MM, Riley EM (2004) Innate immunity to malaria. Nat Rev Immunol 4: 169-180.
3. Baird JK (1995) Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 11: 105-111.
4. Snow RW, Omumbo JA, Lowe B, Molyneux CS, Obiero JO, et al. (1997) Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349: 1650-1654.
5. Schellenberg D, Menendez C, Kahigwa E, Font F, Galindo C, et al. (1999) African children with malaria in an area of intense Plasmodium falciparum transmission: Features on admission to the hospital and risk factors for death. Am J Trop Med Hyg 61: 431-438.
6. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, et al. (1988) Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet 1: 1121-1127.
7. Greenwood BM, David PH, Otoo-Forbes LN, Allen SJ, Alonso PL, et al. (1995) Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 89: 629-633.
8. Otoo LN, Riley EM, Menon A, Byass P, Greenwood BM (1989) Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Trans R Soc Trop Med Hyg 83: 778-782.
9. Otoo LN, Snow RW, Menon A, Byass P, Greenwood BM (1988) Immunity to malaria in young Gambian children after a two-year period of chemoprophylaxis. Trans R Soc Trop Med Hyg 82: 59-65.
10. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, et al. (1997) Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350: 844-850.
11. Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley P, et al. (1993) Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Acta Trop 54: 55-72.
12. Schellenberg D, Menendez C, Aponte J, Guinovart C, Mshinda H, et al. (2004) The changing epidemiology of malaria in Ifakara town, southern Tanzania. Trop Med Int Health 9: 68-76.
13. Drakeley C, Schellenberg D, Kihonda J, Sousa CA, Arez AP, et al. (2003) An estimation of the entomological inoculation rate for Ifakara: A semi-urban area in a region of intense malaria transmission in Tanzania. Trop Med Int Health 8: 767-774.
14. Hatz C, Abdulla S, Mull R, Schellenberg D, Gathmann I, Kibatala P, et al. (1998) Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop Med Int Health 3: 498-504.
15. Alonso PL, Smith T, Schellenberg JR, Masanja H, Mwankusye S, et al. (1994) Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344: 1175-1181.
16. Spiegelhalter DJ, Thomas A, Best N, Lunn D (2003) WinBugs 1.4 [computer program]. Available: http://www.mrc-bsu.cam.ac.uk/bugs. Accessed 22 June 2007.
17. Gelman A (2004) Bugs.R [computer program]. Available: http://www.york.ac. uk/depts/maths/winbugs/bugsr.htm. Accessed 22 June 2007.
18. Gatton ML, Cheng Q (2004) Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria. Infect Immun 72: 6538-6545.
19. Scheller LF, Azad AF (1995) Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci U S A 92: 4066-4068.
20. Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C (1999) Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5: 340-343.
21. Achidi EA, Perlmann H, Salimonu LS, Perlmann P, Walker O, et al. (1995) A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop 59: 173-183.
22. Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, et al. (1995) Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am J Trop Med Hyg 52: 81-88.
23. Trape JF, Rogier C (1996) Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12: 236-240.
24. Snow RW, Marsh K (2002) The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv Parasitol 52: 235-264.
25. Lengeler C, Schellenberg JA, D'Alessandro U (1995) Will reducing Plasmodium falciparum malaria transmission alter malaria mortality among African children? Parasitol Today 11: 425.
26. Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, et al. (2005) Intermittent preventive antimalarial treatment for Tanzanian infants: Follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365: 1481-1483.